Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone prephase with or without vitamin D before immunochemotherapy in elderly DLBCL
2024-511637-35-00Phase 3Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Mar 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cholecalciferol and prednisone in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) (2 arms), sponsored by Fondazione Italiana Linfomi. Primary endpoint: Progression-free survival. Started Mar 2021; status: completed.
02
Drugs
cholecalciferolprednisone
03
Conditions
diffuse large B-cell lymphoma (DLBCL)follicular lymphoma (FL)
Beyond the preview
Go deeper on 2024-511637-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511637-35-00.